Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.01
THC's Cash to Debt is ranked lower than
55% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 0.23 vs. THC: 0.01 )
THC' s 10-Year Cash to Debt Range
Min: 0   Max: 0.35
Current: 0.01

0
0.35
Equity to Asset 0.04
THC's Equity to Asset is ranked lower than
52% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. THC: 0.04 )
THC' s 10-Year Equity to Asset Range
Min: 0   Max: 0.45
Current: 0.04

0
0.45
Interest Coverage 1.40
THC's Interest Coverage is ranked higher than
53% of the 154 Companies
in the Global Medical Care industry.

( Industry Median: 5.49 vs. THC: 1.40 )
THC' s 10-Year Interest Coverage Range
Min: 0.62   Max: 6.4
Current: 1.4

0.62
6.4
F-Score: 4
Z-Score: 0.75
M-Score: -1.91
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 5.97
THC's Operating margin (%) is ranked higher than
67% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 9.44 vs. THC: 5.97 )
THC' s 10-Year Operating margin (%) Range
Min: -14.26   Max: 15.05
Current: 5.97

-14.26
15.05
Net-margin (%) -1.21
THC's Net-margin (%) is ranked higher than
60% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 4.97 vs. THC: -1.21 )
THC' s 10-Year Net-margin (%) Range
Min: -32   Max: 13.5
Current: -1.21

-32
13.5
ROE (%) -17.75
THC's ROE (%) is ranked higher than
51% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 8.44 vs. THC: -17.75 )
THC' s 10-Year ROE (%) Range
Min: -304.17   Max: 64.72
Current: -17.75

-304.17
64.72
ROA (%) -0.83
THC's ROA (%) is ranked higher than
59% of the 235 Companies
in the Global Medical Care industry.

( Industry Median: 3.63 vs. THC: -0.83 )
THC' s 10-Year ROA (%) Range
Min: -27.83   Max: 13.45
Current: -0.83

-27.83
13.45
ROC (Joel Greenblatt) (%) 7.79
THC's ROC (Joel Greenblatt) (%) is ranked higher than
65% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 16.84 vs. THC: 7.79 )
THC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -20.93   Max: 28.47
Current: 7.79

-20.93
28.47
Revenue Growth (%) 21.80
THC's Revenue Growth (%) is ranked higher than
94% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 7.00 vs. THC: 21.80 )
THC' s 10-Year Revenue Growth (%) Range
Min: -13.7   Max: 34.9
Current: 21.8

-13.7
34.9
EBITDA Growth (%) 6.80
THC's EBITDA Growth (%) is ranked higher than
75% of the 171 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. THC: 6.80 )
THC' s 10-Year EBITDA Growth (%) Range
Min: -47.2   Max: 31.5
Current: 6.8

-47.2
31.5
» THC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

THC Guru Trades in Q3 2013

Ray Dalio 16,473 sh (New)
David Tepper 210,000 sh (New)
John Griffin 3,085,000 sh (+45.52%)
Larry Robbins 9,999,339 sh (+1.63%)
Vanguard Health Care Fund 1,400,000 sh (unchged)
Paul Tudor Jones Sold Out
Steven Cohen 208,734 sh (-5.42%)
Jeremy Grantham 20,038 sh (-13.29%)
Jim Simons 247,775 sh (-41.37%)
» More
Q4 2013

THC Guru Trades in Q4 2013

Paul Tudor Jones 5,600 sh (New)
Larry Robbins 13,812,831 sh (+38.14%)
Ray Dalio 21,729 sh (+31.91%)
Vanguard Health Care Fund 1,400,000 sh (unchged)
John Griffin Sold Out
David Tepper Sold Out
Jeremy Grantham 11,743 sh (-41.4%)
Jim Simons 63,075 sh (-74.54%)
Steven Cohen 13,913 sh (-93.33%)
» More
Q1 2014

THC Guru Trades in Q1 2014

Mario Gabelli 15,000 sh (New)
Manning & Napier Advisors, Inc 220,380 sh (New)
Louis Moore Bacon 8,988 sh (New)
Steven Cohen 21,789 sh (+56.61%)
Ray Dalio 33,400 sh (+53.71%)
Vanguard Health Care Fund 1,400,000 sh (unchged)
Larry Robbins 13,812,831 sh (unchged)
Jeremy Grantham Sold Out
Paul Tudor Jones Sold Out
Jim Simons Sold Out
» More
Q2 2014

THC Guru Trades in Q2 2014

Manning & Napier Advisors, Inc 220,380 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with THC

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mario Gabelli 2014-03-31 New Buy$38.9 - $48.33 $ 48.159%15000
Ray Dalio 2014-03-31 Add 53.71%$38.9 - $48.33 $ 48.159%33400
John Griffin 2013-12-31 Sold Out 1.5%$39.81 - $48.26 $ 48.1510%0
Ray Dalio 2013-12-31 Add 31.91%$39.81 - $48.26 $ 48.1510%21729
John Griffin 2013-09-30 Add 45.52%0.47%$38.23 - $45.62 $ 48.1515%3085000
Ray Dalio 2013-09-30 New Buy0.01%$38.23 - $45.62 $ 48.1515%16473
Joel Greenblatt 2013-06-30 Sold Out 0.01%$39.26 - $49.25 $ 48.158%0
John Griffin 2013-03-31 Add 22.19%0.24%$32.47 - $47.58 $ 48.1522%2120000
Joel Greenblatt 2013-03-31 New Buy0.01%$32.47 - $47.58 $ 48.1522%5605
John Griffin 2012-12-31 New Buy0.78%$23.29 - $33.5 $ 48.1577%1735000
John Paulson 2012-06-30 Sold Out 0.1%$17.48 - $21.8 $ 48.15142%0
Joel Greenblatt 2012-06-30 Sold Out 0.05%$17.48 - $21.8 $ 48.15142%0
John Paulson 2012-03-31 Reduce -73%0.27%$18.76 - $23.88 $ 48.15136%2700000
Joel Greenblatt 2012-03-31 Add 36.33%0.01%$18.76 - $23.88 $ 48.15136%109586
John Paulson 2011-12-31 Reduce -50%0.2%$14.36 - $21.04 $ 48.15159%10000000
Vanguard Health Care Fund 2011-12-31 Add 7.69%0.01%$14.36 - $21.04 $ 48.15159%5600000
Vanguard Health Care Fund 2011-09-30 Add 940%0.11%$16.12 - $25.92 $ 48.15130%5200000
Joel Greenblatt 2011-09-30 Add 94.1%0.02%$16.12 - $25.92 $ 48.15130%75374
Richard Perry 2011-06-30 Sold Out 1.64%$23.64 - $30.52 $ 48.1585%0
John Paulson 2011-06-30 New Buy0.43%$23.64 - $30.52 $ 48.1585%20000000
Joel Greenblatt 2011-06-30 New Buy0.03%$23.64 - $30.52 $ 48.1585%38833
Vanguard Health Care Fund 2011-06-30 New Buy0.02%$23.64 - $30.52 $ 48.1585%500000
George Soros 2011-06-30 Sold Out $23.64 - $30.52 $ 48.1585%0
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Tenet Healthcare Corp

Gabelli and Robbins Highlight Guru Buys of the Week
The following information is a highlight of the real-time guru activity we saw this week. To view more information on these gurus, check out their guru portfolios. The “Real Time Picks” reports the stock purchases and sells that Gurus have made within the prior two weeks. If a Guru makes a purchase or sell of a company in which they own a greater-than 5% stake, SEC regulations require them to report their transaction within two days. This week we saw notable increases in Real Time activity from Mario Gabelli and Larry Robbins. Read more...
Larry Robbins Ups Holdings in Health Care Company
Yesterday GuruFocus Real Time Picks reported two guru buys coming from Larry Robbins into the company Tenet Healthcare (THC). The guru made these two buys on two different days over the past week. Read more...
Billionaires Active on PXD, THC, SNI
Here’s the third quarter update for three companies listed among the S&P500’s "biggest losers," including Pioneer Natural Resources Company (PXD), Scripps Networks Interactive Inc. (SNI) and Tenet Healthcare Corp. (THC). Numerous billionaires hold these stocks and there is active insider trading for all three. Read more...

Ratios

vs
industry
vs
history
P/B 6.50
THC's P/B is ranked higher than
56% of the 258 Companies
in the Global Medical Care industry.

( Industry Median: 2.80 vs. THC: 6.50 )
THC' s 10-Year P/B Range
Min: 1.09   Max: 101.5
Current: 6.5

1.09
101.5
P/S 0.40
THC's P/S is ranked higher than
95% of the 258 Companies
in the Global Medical Care industry.

( Industry Median: 1.64 vs. THC: 0.40 )
THC' s 10-Year P/S Range
Min: 0.05   Max: 0.85
Current: 0.4

0.05
0.85
EV-to-EBIT 23.16
THC's EV-to-EBIT is ranked higher than
76% of the 258 Companies
in the Global Medical Care industry.

( Industry Median: 26.54 vs. THC: 23.16 )
THC' s 10-Year EV-to-EBIT Range
Min: 9.4   Max: 31.8
Current: 23.16

9.4
31.8
Shiller P/E 26.90
THC's Shiller P/E is ranked higher than
88% of the 258 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. THC: 26.90 )
THC' s 10-Year Shiller P/E Range
Min: 14.46   Max: 692
Current: 26.9

14.46
692
Current Ratio 1.19
THC's Current Ratio is ranked higher than
67% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 1.40 vs. THC: 1.19 )
THC' s 10-Year Current Ratio Range
Min: 0.9   Max: 2.38
Current: 1.19

0.9
2.38
Quick Ratio 1.11
THC's Quick Ratio is ranked higher than
69% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 1.24 vs. THC: 1.11 )
THC' s 10-Year Quick Ratio Range
Min: 0.85   Max: 2.29
Current: 1.11

0.85
2.29

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 1.00
THC's Price/Median PS Value is ranked higher than
83% of the 258 Companies
in the Global Medical Care industry.

( Industry Median: 1.27 vs. THC: 1.00 )
THC' s 10-Year Price/Median PS Value Range
Min: 0.17   Max: 4.72
Current: 1

0.17
4.72
Earnings Yield (Greenblatt) 4.30
THC's Earnings Yield (Greenblatt) is ranked higher than
67% of the 225 Companies
in the Global Medical Care industry.

( Industry Median: 5.40 vs. THC: 4.30 )
THC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.1   Max: 10.6
Current: 4.3

3.1
10.6
Forward Rate of Return (Yacktman) 2.70
THC's Forward Rate of Return (Yacktman) is ranked higher than
66% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: 10.68 vs. THC: 2.70 )
THC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -108.1   Max: 9.6
Current: 2.7

-108.1
9.6

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:THC1.Germany
Tenet Healthcare Corporation, a Nevada corporation was incorporated in 1975. The Company is an investor-owned health care services company whose subsidiaries and affiliates mainly operate acute care hospitals, ambulatory surgery centers, diagnostic imaging centers and related health care facilities. Its core business is focused on providing acute care treatment, including inpatient care, intensive care, cardiac care, radiology services and emergency medical treatment. Its subsidiaries operated 49 hospitals, including three academic medical centers and a critical access hospital, with a combined total of 13,216 licensed beds, serving mainly urban and suburban communities in 10 states. Each of its general hospitals offers acute care services, operating and recovery rooms, radiology services, respiratory therapy services, clinical laboratories and pharmacies; in addition, most offer intensive care, critical care and/or coronary care units, physical therapy, and orthopedic, oncology and outpatient services. A number of its hospitals also offer tertiary care services such as open-heart surgery, neonatal intensive care and neuroscience. Two of its hospitals — St. Louis University Hospital and Hahnemann University Hospital — offer quaternary care in areas such as heart, liver, kidney and bone marrow transplants. St. Christopher's Hospital for Children provides tertiary and quaternary pediatric services, including bone marrow and kidney transplants, as well as burn services. Sierra Medical Center, Good Samaritan Medical Center and North Shore Medical Center offer gamma-knife brain surgery; and Brookwood Medical Center, North Shore Medical Center, Saint Francis Hospital and St. Louis University Hospital offers cyberknife radiation therapy for tumors and lesions nearly anywhere in the body, including in the brain, lung, neck and spine that may have been previously considered inoperable or inaccessible by traditional radiation therapy. In addition, its hospitals will continue their efforts to deliver and develop those outpatient services that can be provided on a quality, cost-effective basis. The Company is facing competition from specialty hospitals (some of which are physician-owned) and unaffiliated freestanding outpatient centers for market share in high margin services and for quality physicians and personnel. Furthermore, some of the hospitals that compete with its hospitals are owned by government agencies or not-for-profit organizations. The Company is subject to a number of laws and regulations affecting its use of, and purchase and sale of, real property. Among these are California's seismic standards, the Americans with Disabilities Act, and various environmental laws and regulations.
» More Articles for THC

Headlines

Articles On GuruFocus.com
A Far-Larger Hospital and a Far-Larger Stock Position Jan 02 2014 
Gabelli and Robbins Highlight Guru Buys of the Week Dec 27 2013 
Larry Robbins Ups Holdings in Health Care Company Dec 24 2013 
Robbins, Cohen and Karr Highlight the Guru Real Time Picks of the Week Dec 20 2013 
Glenview Capital - Larry Robbins in Real Time and Review Nov 15 2013 
Blue Ridge Capital Buys Charter Communications, American Homes 4 Rent, Tesla Motors, Sells Owens-Cor Nov 14 2013 
Billionaires Active on PXD, THC, SNI Nov 10 2013 
Real-Time Rodeo and Round Up - Reduction Trades May 24 2013 
John Griffin's Top 5 Increases of the First Quarter May 24 2013 
Robbins’ HMA Stake Just Keeps Getting Bigger Jan 11 2013 

More From Our Partners
Obamacare Plays: 3 Hospital Stocks to Buy - Analyst Blog Jul 17 2014 - ZACKS

More From Other Websites
The Zacks Analyst Blog Highlights: HCA Holdings, Acadia Healthcare, Tenet Healthcare, Cigna and... Jul 18 2014
Catholic Health Initiatives and Conifer Health Solutions To Address 2014 AHA Leadership Summit Jul 17 2014
Tenet Healthcare (THC) Jumps: Stock Up 8.3% Jul 17 2014
Video: HCA Guides Up But May Still Be Too Cautious Jul 16 2014
Hospitals advance after HCA preliminary results beat expectations Jul 16 2014
HCA, Tenet Healthcare shares surge in early trade Jul 16 2014
HCA Holdings guidance increase looks conservative, says Wells Fargo Jul 16 2014
Tenet Healthcare Extends Contract with Humana to Drive Growth Jul 15 2014
Why Tenet Healthcare Is a Buy Jul 14 2014
Tenet and Humana Sign New Multi-Year National Agreement Jul 14 2014
Humana, Tenet sign new multi-year national agreement Jul 14 2014
Tenet and Humana Sign New Multi-Year National Agreement Jul 14 2014
Tenet Healthcare's Acquisition Plans Look Promising Jul 11 2014
Call selling hits Tenet Healthcare Jul 11 2014
Roger Rydell Joins Conifer Health Solutions® as Vice President of Marketing & Communications Jul 09 2014
Tenet to Report Second Quarter Results on August 4, 2014 Jul 09 2014
Tenet to Report Second Quarter Results on August 4, 2014 Jul 09 2014
Tenet adds Saint Mary's to acquisition plans Jul 09 2014
Tenet adds Saint Mary's to acquisition plans Jul 09 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide